235 related articles for article (PubMed ID: 2174164)
1. Purification and characterization of an inhibitor (soluble tumor necrosis factor receptor) for tumor necrosis factor and lymphotoxin obtained from the serum ultrafiltrates of human cancer patients.
Gatanaga T; Hwang CD; Kohr W; Cappuccini F; Lucci JA; Jeffes EW; Lentz R; Tomich J; Yamamoto RS; Granger GA
Proc Natl Acad Sci U S A; 1990 Nov; 87(22):8781-4. PubMed ID: 2174164
[TBL] [Abstract][Full Text] [Related]
2. Identification of TNF-LT blocking factor(s) in the serum and ultrafiltrates of human cancer patients.
Gatanaga T; Lentz R; Masunaka I; Tomich J; Jeffes EW; Baird M; Granger GA
Lymphokine Res; 1990; 9(2):225-9. PubMed ID: 2187118
[TBL] [Abstract][Full Text] [Related]
3. Identification of tumor necrosis factor and lymphotoxin blocking factor(s) in the ascites of patients with advanced and recurrent ovarian cancer.
Cappuccini F; Yamamoto RS; DiSaia PJ; Grosen EA; Gatanaga M; Lucci JA; Ininns EK; Gatanaga T; Granger GA
Lymphokine Cytokine Res; 1991 Jun; 10(3):225-9. PubMed ID: 1653048
[TBL] [Abstract][Full Text] [Related]
4. Blocking factors (soluble membrane receptors) for tumor necrosis factor and lymphotoxin detected in ascites and released in short-term cultures obtained from ascites and solid tumors in women with gynecologic malignancy.
Grosen EA; Yamamoto RS; Ioli G; Ininns EK; Gatanaga M; Gatanaga T; DiSaia PJ; Berman M; Manetta A; Granger GA
Lymphokine Cytokine Res; 1992 Dec; 11(6):347-53. PubMed ID: 1335764
[TBL] [Abstract][Full Text] [Related]
5. Purification and partial amino acid sequence analysis of two distinct tumor necrosis factor receptors from HL60 cells.
Loetscher H; Schlaeger EJ; Lahm HW; Pan YC; Lesslauer W; Brockhaus M
J Biol Chem; 1990 Nov; 265(33):20131-8. PubMed ID: 2173696
[TBL] [Abstract][Full Text] [Related]
6. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes.
Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL
J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of the extracellular domain of the 75-kilodalton tumor necrosis factor receptor.
Pennica D; Lam VT; Weber RF; Kohr WJ; Basa LJ; Spellman MW; Ashkenazi A; Shire SJ; Goeddel DV
Biochemistry; 1993 Mar; 32(12):3131-8. PubMed ID: 8384489
[TBL] [Abstract][Full Text] [Related]
8. Characterization of a recombinant extracellular domain of the type 1 tumor necrosis factor receptor: evidence for tumor necrosis factor-alpha induced receptor aggregation.
Pennica D; Kohr WJ; Fendly BM; Shire SJ; Raab HE; Borchardt PE; Lewis M; Goeddel DV
Biochemistry; 1992 Feb; 31(4):1134-41. PubMed ID: 1310420
[TBL] [Abstract][Full Text] [Related]
9. Human tumor necrosis factor. Production, purification, and characterization.
Aggarwal BB; Kohr WJ; Hass PE; Moffat B; Spencer SA; Henzel WJ; Bringman TS; Nedwin GE; Goeddel DV; Harkins RN
J Biol Chem; 1985 Feb; 260(4):2345-54. PubMed ID: 3871770
[TBL] [Abstract][Full Text] [Related]
10. A 20 amino acid synthetic peptide of a region from the 55 kDa human TNF receptor inhibits cytolytic and binding activities of recombinant human tumour necrosis factor in vitro.
Hwang CD; Gatanaga M; Innins EK; Yamamoto RS; Granger GA; Gatanaga T
Proc Biol Sci; 1991 Aug; 245(1313):115-9. PubMed ID: 1682934
[TBL] [Abstract][Full Text] [Related]
11. A second tumor necrosis factor receptor gene product can shed a naturally occurring tumor necrosis factor inhibitor.
Kohno T; Brewer MT; Baker SL; Schwartz PE; King MW; Hale KK; Squires CH; Thompson RC; Vannice JL
Proc Natl Acad Sci U S A; 1990 Nov; 87(21):8331-5. PubMed ID: 2172983
[TBL] [Abstract][Full Text] [Related]
12. Characterization of recombinant human lymphotoxin (tumor necrosis factor-beta) produced by a mammalian cell line.
Hains JM; Aggarwal BB
Arch Biochem Biophys; 1989 Nov; 274(2):417-25. PubMed ID: 2802619
[TBL] [Abstract][Full Text] [Related]
13. Differences in the bioactivity of recombinant human TNF, LT, and T-cell-derived LT-3 on transformed cells in vitro and the Meth A tumor growing in BALB/c mice.
Granger GA; Masunaka I; Averbook B; Kobayashi M; Fitzgerald M; Yamamoto R
J Biol Response Mod; 1988 Oct; 7(5):488-97. PubMed ID: 3263472
[TBL] [Abstract][Full Text] [Related]
14. Identification, purification, and characterization of a mast cell-associated cytolytic factor related to tumor necrosis factor.
Young JD; Liu CC; Butler G; Cohn ZA; Galli SJ
Proc Natl Acad Sci U S A; 1987 Dec; 84(24):9175-9. PubMed ID: 3321069
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the receptor for tumor necrosis factor (TNF) and lymphotoxin (LT) on human T lymphocytes. TNF and LT differ in their receptor binding properties and the induction of MHC class I proteins on a human CD4+ T cell hybridoma.
Andrews JS; Berger AE; Ware CF
J Immunol; 1990 Apr; 144(7):2582-91. PubMed ID: 1969453
[TBL] [Abstract][Full Text] [Related]
16. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
[TBL] [Abstract][Full Text] [Related]
17. Lymphotoxin but not tumor necrosis factor functions to maintain splenic architecture and humoral responsiveness in adult mice.
Mackay F; Majeau GR; Lawton P; Hochman PS; Browning JL
Eur J Immunol; 1997 Aug; 27(8):2033-42. PubMed ID: 9295042
[TBL] [Abstract][Full Text] [Related]
18. In vitro comparison of inhibiting ability of soluble TNF receptor p75 (TBP II) vs. soluble TNF receptor p55 (TBP I) against TNF-alpha and TNF-beta.
Terlizzese M; Simoni P; Antonetti F
J Interferon Cytokine Res; 1996 Dec; 16(12):1047-53. PubMed ID: 8974008
[TBL] [Abstract][Full Text] [Related]
19. Purification and biologic characterization of a specific tumor necrosis factor alpha inhibitor.
Seckinger P; Isaaz S; Dayer JM
J Biol Chem; 1989 Jul; 264(20):11966-73. PubMed ID: 2545692
[TBL] [Abstract][Full Text] [Related]
20. Protection against endotoxic shock by a tumor necrosis factor receptor immunoadhesin.
Ashkenazi A; Marsters SA; Capon DJ; Chamow SM; Figari IS; Pennica D; Goeddel DV; Palladino MA; Smith DH
Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10535-9. PubMed ID: 1660140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
